Clinical Trial Detail

NCT ID NCT02540161
Title Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Annick Desjardins
Indications

malignant glioma

Therapies

SYM004

Age Groups: adult

No variant requirements are available.